
Opinion|Videos|September 10, 2025
Analyzing the Safety Data of JAK Inhibitors
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss the key safety data observed with each of the three Janus kinase (JAK) inhibitors for alopecia areata (AA), highlighting potential adverse effects and how these impact clinical decision-making.
Advertisement
Video content above is prompted by the following:
- Mostaghimi: Please discuss key safety data seen with each of the 3 JAK inhibitors.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
White House, Pfizer Reach Agreement on Drug Discounts; Trump Announces TrumpRx
2
Predicting Patient Response in the Move Toward Precision Medicine in Myasthenia Gravis
3
FDA Approves Remibrutinib for Chronic Spontaneous Urticaria
4
AI Seen as Key to Reducing Health Care Claim Denials, Survey Finds
5